Serum and mucosal brain derived neurotrophic factor (BDNF) in severe obstructive sleep apnea syndrome (OSAS). Effects of CPAP treatment on BDNF serum levels.

K. Flores (Rome, Italy), F. Viccaro (Rome, Italy), M. Aquilini (Rome, Italy), F. Ronchetti (Rome, Italy), S. Scarpino (Rome, Italy), A. Di Napoli (Rome, Italy), G. Scafetta (Rome, Italy), P. Palange (Rome, Italy), A. Ricci (Rome, Italy)

Source: International Congress 2019 – Beyond continuous positive airway pressure treatment
Session: Beyond continuous positive airway pressure treatment
Session type: Thematic Poster
Number: 4177
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Flores (Rome, Italy), F. Viccaro (Rome, Italy), M. Aquilini (Rome, Italy), F. Ronchetti (Rome, Italy), S. Scarpino (Rome, Italy), A. Di Napoli (Rome, Italy), G. Scafetta (Rome, Italy), P. Palange (Rome, Italy), A. Ricci (Rome, Italy). Serum and mucosal brain derived neurotrophic factor (BDNF) in severe obstructive sleep apnea syndrome (OSAS). Effects of CPAP treatment on BDNF serum levels.. 4177

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: